Blog | shawview-consulting

top of page

Our Blog

See below for an opinion on current matters around the world.

Search

One-quarter through the 21st century, how are we going?

One-quarter through the 21st century, how are we going?

One-quarter through the 21st century, how are we going?

Brendan Shaw

Dec 110 min read

The Dismissal in Australia 50 years on: Lessons on the fragility of democracy

The Dismissal in Australia 50 years on: Lessons on the fragility of democracy

The Dismissal in Australia 50 years on: Lessons on the fragility of democracy

Brendan Shaw

Nov 108 min read

‘Most Favored Nation’ Pricing & Tariffs: Pharma Leadership in Uncertain Times

‘Most Favored Nation’ Pricing & Tariffs: Pharma Leadership in Uncertain Times

‘Most Favored Nation’ Pricing & Tariffs: Pharma Leadership in Uncertain Times

Brendan Shaw

Oct 91 min read

WHO Model List of Essential Medicines 2025 Update: New Tech, Emerging Issues & 50th Anniversary

WHO Model List of Essential Medicines 2025 Update: New Tech, Emerging Issues & 50th Anniversary

WHO Model List of Essential Medicines 2025 Update: New Tech, Emerging Issues & 50th Anniversary

Brendan Shaw

Sep 111 min read

People, productivity and punctuality: Post-pandemic office warfare continues

People, productivity and punctuality: Post-pandemic office warfare continues

People, productivity and punctuality: Post-pandemic office warfare continues

Brendan Shaw

Aug 196 min read

The ‘Canberra Hypothesis' 50 years on: what can we learn about the pricing and economics of the pharmaceutical industry?

The ‘Canberra Hypothesis' 50 years on: what can we learn about the pricing and economics of the pharmaceutical industry?

The ‘Canberra Hypothesis' 50 years on: what can we learn about the pricing and economics of the pharmaceutical industry?

Brendan Shaw

Jul 16 min read

Never Waste a Good Crisis: Reflections on the 2025 World Health Assembly

Never Waste a Good Crisis: Reflections on the 2025 World Health Assembly

Never Waste a Good Crisis: Reflections on the 2025 World Health Assembly

Brendan Shaw

Jun 31 min read

IMF says better investment in health programs could boost global economic growth and productivity

IMF says better investment in health programs could boost global economic growth and productivity

IMF says better investment in health programs could boost global economic growth and productivity

Brendan Shaw

Apr 306 min read

Politicians, Pills and Penguins: Pharmaceuticals Feature in Australian National Elections Again

Politicians, Pills and Penguins: Pharmaceuticals Feature in Australian National Elections Again

Politicians, Pills and Penguins: Pharmaceuticals Feature in Australian National Elections Again

Brendan Shaw

Apr 181 min read

Costs and benefits: how has the Pharmaceutical Benefits Scheme contributed to Australia over the last quarter century?

Costs and benefits: how has the Pharmaceutical Benefits Scheme contributed to Australia over the last quarter century?

Costs and benefits: how has the Pharmaceutical Benefits Scheme contributed to Australia over the last quarter century?

Brendan Shaw

Mar 258 min read

Recognising rebates: the role of pharmaceutical companies in funding UK and Australian pharmaceutical schemes

Recognising rebates: the role of pharmaceutical companies in funding UK and Australian pharmaceutical schemes

Recognising rebates: the role of pharmaceutical companies in funding UK and Australian pharmaceutical schemes

Brendan Shaw

Feb 257 min read

The Best & the Worst? Five Trends for Pharma to Watch in 2025

The Best & the Worst? Five Trends for Pharma to Watch in 2025

The Best & the Worst? Five Trends for Pharma to Watch in 2025

Brendan Shaw

Jan 91 min read

Blocs, shocks and two smoking ballots: 2024 and the world’s mega election year

Blocs, shocks and two smoking ballots: 2024 and the world’s mega election year

Blocs, shocks and two smoking ballots: 2024 and the world’s mega election year

Brendan Shaw

Dec 3, 202411 min read

Raising the Bar: How the 2024 Access to Medicine Index Shapes the Pharmaceutical Industry’s ESG Agenda

Raising the Bar: How the 2024 Access to Medicine Index Shapes the Pharmaceutical Industry’s ESG Agenda

Raising the Bar: How the 2024 Access to Medicine Index Shapes the Pharmaceutical Industry’s ESG Agenda

Brendan Shaw

Dec 2, 20244 min read

The Good, the Bad, and the Ugly: Australia’s HTA Review Final Report

The Good, the Bad, and the Ugly: Australia’s HTA Review Final Report

The Good, the Bad, and the Ugly: Australia’s HTA Review Final Report

Brendan Shaw

Nov 13, 20247 min read

Is the new price right?: HTA takes a back seat to broader price negotiations

Is the new price right?: HTA takes a back seat to broader price negotiations

Is the new price right?: HTA takes a back seat to broader price negotiations

Brendan Shaw

Oct 26, 20247 min read

Could Human HTA Committees be Replaced with AI Systems?

Could Human HTA Committees be Replaced with AI Systems?

Could Human HTA Committees be Replaced with AI Systems?

Brendan Shaw

Sep 20, 20241 min read

WFH ... WTF ... ????: Working-from-home, employer reaction and pandemic-inspired industrial changes

WFH ... WTF ... ????: Working-from-home, employer reaction and pandemic-inspired industrial changes

WFH ... WTF ... ????: Working-from-home, employer reaction and pandemic-inspired industrial changes

Brendan Shaw

Aug 7, 20248 min read

It’s not easy being green: environmental sustainability in health systems, health industries and health economics

It’s not easy being green: environmental sustainability in health systems, health industries and health economics

It’s not easy being green: environmental sustainability in health systems, health industries and health economics

Brendan Shaw

Jul 25, 20248 min read

Short Memories: Has Health Fallen Off the Global Agenda? What Does it Mean for Pharma?

Short Memories: Has Health Fallen Off the Global Agenda? What Does it Mean for Pharma?

Short Memories: Has Health Fallen Off the Global Agenda? What Does it Mean for Pharma?

Brendan Shaw

Jun 27, 20241 min read

bottom of page